Clinical Trial Update: Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab plus actinomycin-D as first-line therapy for gestational trophoblastic neoplasia with FIGO score 7; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Neoplasia

Drugs mentioned

• Actinomycin D (dactinomycin)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Gestational Trophoblastic Neoplasia | Phase 2 | Status: RECRUITING